Selected article for: "acute respiratory and added benefit"

Author: Fatmi, Syed S; Basso, Rafaela; Liaqat, Adnan; Tariq, Fateeha; Swamiappan, Ramesh
Title: COVID-19 Myocarditis: Rationale for Early Diagnosis and Intervention
  • Cord-id: r4vzep6r
  • Document date: 2021_7_19
  • ID: r4vzep6r
    Snippet: Myocarditis is a common cardiovascular manifestation seen in patients diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, because of the similarity of presentation with other cardiopulmonary pathologies, identification of coronavirus disease 2019 (COVID-19) related myocarditis can be challenging. Transthoracic echocardiography is a key component in initial diagnosis. COVID-19 related myocarditis is increasingly identified as an underlying problem in CO
    Document: Myocarditis is a common cardiovascular manifestation seen in patients diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, because of the similarity of presentation with other cardiopulmonary pathologies, identification of coronavirus disease 2019 (COVID-19) related myocarditis can be challenging. Transthoracic echocardiography is a key component in initial diagnosis. COVID-19 related myocarditis is increasingly identified as an underlying problem in COVID-19 patients with low ejection fraction. Early recognition is critical with a low threshold for screening echocardiogram. Utilization of cardiac MRI (CMRI) can be helpful in recognition of early manifestations of COVID-19 myocarditis, with the added benefit of avoidance of invasive testing such as endomyocardial biopsy (EMB). Once diagnosis is established, disease-specific treatment can lead to rapid recovery of ventricular systolic function. We present a case series including two similar cases of COVID-19 myocarditis in which we utilized echocardiography as an early diagnostic tool and prompt treatment led to better prognosis.

    Search related documents:
    Co phrase search for related documents
    • activity relationship and acute respiratory failure: 1
    • activity relationship and magnetic resonance: 1, 2, 3, 4, 5, 6
    • acute coronary artery occlusion and lvef ventricular ejection fraction: 1
    • acute coronary syndrome and long term sequelae: 1
    • acute coronary syndrome and low threshold: 1
    • acute coronary syndrome and lvef ventricular ejection fraction: 1, 2, 3, 4, 5, 6
    • acute coronary syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute infarction and long term sequelae: 1, 2
    • acute infarction and lvef ventricular ejection fraction: 1, 2
    • acute infarction and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute myocardial infarction and long term sequelae: 1, 2
    • acute myocardial infarction and lvef ventricular ejection fraction: 1, 2
    • acute myocardial infarction and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory failure and long term sequelae: 1
    • acute respiratory failure and low threshold: 1
    • acute respiratory failure and lvef ventricular ejection fraction: 1
    • acute respiratory failure and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • long term sequelae and lvef estimate: 1
    • long term sequelae and lvef ventricular ejection fraction: 1, 2